During the past decade, Retina Associates of Florida, LLC conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 13 clinical trials were completed, i.e. on average, 52% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Associates of Florida, LLC" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Jaeb Center for Health Research" with 6 trials sponsored, "Kodiak Sciences Inc" with 4 trials sponsored, "Apellis Pharmaceuticals, Inc." with 2 trials sponsored and "Retina Associates of Florida, P.A." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Associates of Florida, LLC" #1 collaborator was "National Eye Institute (NEI)" with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Retina Associates of Florida, LLC" are "Diabetic Macular Edema" (10 trials), "Macular Edema" (4 trials), "Geographic Atrophy" (3 trials), "Branch Retinal Vein Occlusion" (2 trials) and "Diabetic Retinopathy" (2 trials). Many other conditions were trialed in "Retina Associates of Florida, LLC" in a lesser frequency.

Most popular intervention types in "Retina Associates of Florida, LLC" are "Drug" (30 trials), "Procedure" (10 trials), "Other" (8 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (11 trials), "Aflibercept" (8 trials), "Faricimab" (6 trials), "KSI-301" (4 trials) and "Deferred aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Associates of Florida, LLC" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Retina Associates of Florida, LLC". undefined are not yet recruiting, 2 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Retina Associates of Florida, LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Associates of Florida, LLC, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".